Arjun Balar in

Arjun Balar

Login to view DISC.
SVP and Head of Oncology Global Clinical Development at Eli Lilly and Company
📍 New York City Metropolitan Area, United States

Arjun Balar is the SVP and Head of Oncology Global Clinical Development at Eli Lilly & Co., where he leads development programs for various cancer treatments. An internationally recognized expert in urothelial cancers, he previously directed the Genitourinary Medical Oncology Program at NYU Langone Health. He earned his MD at the University of South Florida.

He led the clinical development of novel immunotherapies and antibody-drug conjugates at NYU that have since become global standards of care for bladder cancer.

Read the full overview →
Experience
19 Years
Current Role
SVP and Head of Oncology Global Clinical Development
Job Level
Leadership
Location
New York City Metropolitan Area, United States
Personality Overview

How Arjun shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Arjun cares about

Bladder Cancer Research
He is an internationally recognized expert in urothelial cancers and has led numerous clinical trials focused on developing new treatments for the disease.
Immunotherapy Development
His research and clinical work have heavily focused on advancing immunotherapies, such as immune checkpoint inhibitors, to improve patient outcomes in oncology.
+6 more topics Login to view topics
Career

Work history

2-2026
SVP and Head of Oncology Global Clinical Development
Eli Lilly and Company
4-2023
Board Member
Volastra Therapeutics
1-2023 - 2-2026
Senior Vice President - Global Clinical Development
Eli Lilly and Company
12-2021 - 1-2023
Vice President - Global Clinical Development
Loxo Oncology at Lilly
6-2020 - 11-2021
Director - Clinical Trials Office, Perlmutter Cancer Center
NYU Langone Health
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2002 - 2006
MD
University of South Florida College of Medicine
1998 - 2002
BS
University of Florida
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Eli Lilly and Company Employees

Explore more public profiles from related professionals.

Keith Mayl, MD, PhD
Keith Mayl, MD, PhD
Associate Vice President - Neurodegenerative Disease Early Phase Clinical Development
Eli Lilly and Company
 Marc Mazarin
Marc Mazarin
Senior Director of Masterbrand Marketing
Eli Lilly and Company
 Abdullah Almuqaytib, MBA, SHRM-SCP
Abdullah Almuqaytib, MBA, SHRM-SCP
Associate Director - Talent Development
Eli Lilly and Company
 Zerrin Oyan Eter
Zerrin Oyan Eter
Director Corporate Affairs & Pricing, Reimbursement & Access, Türkiye at Eli Lilly
Eli Lilly and Company

More profiles

Discover additional public profiles from our index.

MK
Mike Kobel
Associate Director, Analytical Research & Development
Lannett Company, Inc.
JM
John McLemore
Director of Continuous Improvement
Lannett Company, Inc.
MC
Maureen Cavanaugh
SVP, Chief Commercial Officer
Lannett Company
 Scott Newman
Scott Newman
Chief Operating Officer (COO)
Brandywine Group Advisors
Unlock the full playbookSee exactly how to sell to Arjun. Free, 10 seconds.